Top of the Street: AstraZeneca, BNP Paribas, Unibail

Unibail-Rodamco-Westfield SE

09/02/2024 13:26

A round-up of notable broker activity this morning from Europe's
top-ranked* analysts:
    
    ** Deutsche Bank cuts London-listed drugmaker AstraZeneca
 AZN.L  to "sell" from "hold" as it finds the flat dividend to
be another disappointment
    ** UBS cuts BNP Paribas  BNPP.PA  to "neutral" from "buy"
and removes the French lender from its top European bank picks
as its PBT forecasts are 7-12% below company consensus
    ** Jefferies cuts French shopping mall owner
Unibail-Rodamco-Westfield  URW.PA  to "hold" from "buy" as it
expects the stock's valuation to normalise this year after a
strong rally, with the shares now offering not enough upside to
justify a "buy" rating
   
    
(*Analyst rankings from Thomson Reuters StarMine. The scale is
from 1-star to 5-star with 5 being the best. Analysts are ranked
on earnings accuracy as well as relative performance of
recommendations over trailing 12-month & 24-month periods.)


 (Reporting by Elviira Luoma and Olivier Cherfan)
 ((Elviira.luoma@thomsonreuters.com))